| Dr Kimberly Rachel Brandt, DO | |
|
1 Hospital Dr, Columbia, MO 65212-1000 | |
| (573) 882-8913 | |
| (573) 884-1070 |
| Full Name | Dr Kimberly Rachel Brandt |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1 Hospital Dr, Columbia, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497066740 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 2014020132 (Missouri) | Primary |
| Entity Name | Compass Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285619494 PECOS PAC ID: 1951206754 Enrollment ID: O20040408000955 |
News Archive
Prostate cancer is one of the most common cancers in America and may lead to more than 32,000 deaths this year. Medical Doctor and cancer expert, Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer.
A commonly used pesticide may alter the development of the brain's dopamine system - responsible for emotional expression and cognitive function - and increase the risk of attention deficit hyperactivity disorder in children, according to a new Rutgers study.
Current cigarette smoking among 12- to 17-year-olds fell significantly from 2002 to 2010 in 41 states, according to a report by the Substance Abuse and Mental Health Services Administration.
Employers say that back pain-related problems account for over 100 million lost workdays a year. In a cutthroat economy with unemployment at a record high, this is especially disconcerting news. Employees cannot afford to risk losing their jobs to other candidates while stuck home in bed recuperating. With 80% of Americans experiencing back pain in their lifetime, back issues have serious implications on job security and can negatively affect even the most dedicated employee's performance abilities and job attendance.
Idera Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that enrollment is open for a Phase 1/2 clinical trial of IMO-8400 in patients with Waldenström's macroglobulinemia, following acceptance of its Investigational New Drug application by the U.S. Food and Drug Administration.
› Verified 5 days ago
| Entity Name | Mercy Clinic Adult Psychiatry Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750788972 PECOS PAC ID: 4688998602 Enrollment ID: O20150122002258 |
News Archive
Prostate cancer is one of the most common cancers in America and may lead to more than 32,000 deaths this year. Medical Doctor and cancer expert, Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer.
A commonly used pesticide may alter the development of the brain's dopamine system - responsible for emotional expression and cognitive function - and increase the risk of attention deficit hyperactivity disorder in children, according to a new Rutgers study.
Current cigarette smoking among 12- to 17-year-olds fell significantly from 2002 to 2010 in 41 states, according to a report by the Substance Abuse and Mental Health Services Administration.
Employers say that back pain-related problems account for over 100 million lost workdays a year. In a cutthroat economy with unemployment at a record high, this is especially disconcerting news. Employees cannot afford to risk losing their jobs to other candidates while stuck home in bed recuperating. With 80% of Americans experiencing back pain in their lifetime, back issues have serious implications on job security and can negatively affect even the most dedicated employee's performance abilities and job attendance.
Idera Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that enrollment is open for a Phase 1/2 clinical trial of IMO-8400 in patients with Waldenström's macroglobulinemia, following acceptance of its Investigational New Drug application by the U.S. Food and Drug Administration.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kimberly Rachel Brandt, DO Po Box 843966, Kansas City, MO 64184-3966 Ph: (573) 884-3300 | Dr Kimberly Rachel Brandt, DO 1 Hospital Dr, Columbia, MO 65212-1000 Ph: (573) 882-8913 |
News Archive
Prostate cancer is one of the most common cancers in America and may lead to more than 32,000 deaths this year. Medical Doctor and cancer expert, Dr. Isaac Eliaz announces breakthrough research and essential recommendations for the prevention and treatment of prostate cancer.
A commonly used pesticide may alter the development of the brain's dopamine system - responsible for emotional expression and cognitive function - and increase the risk of attention deficit hyperactivity disorder in children, according to a new Rutgers study.
Current cigarette smoking among 12- to 17-year-olds fell significantly from 2002 to 2010 in 41 states, according to a report by the Substance Abuse and Mental Health Services Administration.
Employers say that back pain-related problems account for over 100 million lost workdays a year. In a cutthroat economy with unemployment at a record high, this is especially disconcerting news. Employees cannot afford to risk losing their jobs to other candidates while stuck home in bed recuperating. With 80% of Americans experiencing back pain in their lifetime, back issues have serious implications on job security and can negatively affect even the most dedicated employee's performance abilities and job attendance.
Idera Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today announced that enrollment is open for a Phase 1/2 clinical trial of IMO-8400 in patients with Waldenström's macroglobulinemia, following acceptance of its Investigational New Drug application by the U.S. Food and Drug Administration.
› Verified 5 days ago
Dr. Anasseril E Daniel, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 33 E Broadway Ste 115, Columbia, MO 65203 Phone: 573-443-6930 Fax: 573-875-4272 | |
Dr. Joseph J. Parks, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Family Health Center Of Boone County, 1001 West Worley, Columbia, MO 35203 Phone: 573-214-2314 Fax: 573-814-2784 | |
Dr. Robert Edward Frazier, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 367 Crown Pt, Columbia, MO 65203 Phone: 573-442-4346 Fax: 573-443-2027 | |
Myles Brandon Goble, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 525 N. Keene Street, Suite 301, Columbia, MO 65201 Phone: 573-882-2260 Fax: 573-884-4249 | |
Ashutosh Pandey, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1020 Hitt St, Columbia, MO 65212 Phone: 573-882-1515 | |
Jeffrey Thiele, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Lisa A Lacey, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6480 |